Human CYR 61

Human CYR 61

  • CN 1,447,819 A
  • Filed: 01/31/2001
  • Published: 10/08/2003
  • Est. Priority Date: 01/31/2000
  • Status: Abandoned Application
First Claim
Patent Images

1. method that is used to screen the cytoadherence conditioning agent, the step of this method comprises:

  • (a) first inoblast is contacted with a kind of cytoadherence conditioning agent to be detected and a kind of ECM signaling molecule associated biomolecule material of biology effective dose, this biomaterial is selected from people Cyr61, people Cyr61 fragment, people Cyr61 analogue and people Cyr61 derivative;

    (b) second inoblast is contacted separately with a kind of ECM signaling molecule associated biomolecule material of biology effective dose, and with this in contrast, this biomaterial is selected from people Cyr61, people Cyr61 fragment, people Cyr61 analogue and people Cyr61 derivative;

    (c) measure the cytoadherence level that causes by step (a) and step (b);

    And(d) the cytoadherence level of measuring in the comparison step (c), thus come identification of cell adhesion conditioning agent by the change ability of the pair cell adhesion level compared with the contrast of step (b).

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×